{"doi":"10.1016/j.ebiom.2024.104977","title":"Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes","abstract":"BACKGROUND: Type 2 diabetes is associated with higher risk of several cancer types. However, the biological intermediates driving this relationship are not fully understood. As novel interventions for treating and managing type 2 diabetes become increasingly available, whether they also disrupt the pathways leading to increased cancer risk is currently unknown. We investigated the effect of a type 2 diabetes intervention, in the form of intentional weight loss, on circulating proteins associated with cancer risk to gain insight into potential mechanisms linking type 2 diabetes and adiposity with cancer development. METHODS: Fasting serum samples from participants with diabetes enrolled in the Diabetes Remission Clinical Trial (DiRECT) receiving the Counterweight-Plus weight-loss programme (intervention, N = 117, mean weight-loss 10 kg, 46% diabetes remission) or best-practice care by guidelines (control, N = 143, mean weight-loss 1 kg, 4% diabetes remission) were subject to proteomic analysis using the Olink Oncology-II platform (48% of participants were female; 52% male). To identify proteins which may be altered by the weight-loss intervention, the difference in protein levels between groups at baseline and 1 year was examined using linear regression. Mendelian randomization (MR) was performed to extend these results to evaluate cancer risk and elucidate possible biological mechanisms linking type 2 diabetes and cancer development. MR analyses were conducted using independent datasets, including large cancer meta-analyses, UK Biobank, and FinnGen, to estimate potential causal relationships between proteins modified during intentional weight loss and the risk of colorectal, breast, endometrial, gallbladder, liver, and pancreatic cancers. FINDINGS: Nine proteins were modified by the intervention: glycoprotein Nmb; furin; Wnt inhibitory factor 1; toll-like receptor 3; pancreatic prohormone; erb-b2 receptor tyrosine kinase 2; hepatocyte growth factor; endothelial cell specific molecule 1 and Ret proto-oncogene (Holm corrected P-value <0.05). Mendelian randomization analyses indicated a causal relationship between predicted circulating furin and glycoprotein Nmb on breast cancer risk (odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.67-0.99, P-value = 0.03; and OR = 0.88, 95% CI = 0.78-0.99, P-value = 0.04 respectively), though these results were not supported in sensitivity analyses examining violations of MR assumptions. INTERPRETATION: Intentional weight loss among individuals with recently diagnosed diabetes may modify levels of cancer-related proteins in serum. Further evaluation of the proteins identified in this analysis could reveal molecular pathways that mediate the effect of adiposity and type 2 diabetes on cancer risk. FUNDING: The main sources of funding for this work were Diabetes UK, Cancer Research UK, World Cancer Research Fund, and Wellcome.","journal":"EBioMedicine","year":2024,"id":439642,"datarank":0.3453877639491069,"base_score":2.302585092994046,"endowment":2.302585092994046,"self_citation_contribution":0.3453877639491069,"citation_network_contribution":0.0,"self_endowment_contribution":0.3453877639491069,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9655,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":813503,"name":"Emma Hazelwood","orcid":"0000-0002-4888-6037","position":1,"is_corresponding":false},{"id":695611,"name":"Danny Legge","orcid":"0000-0002-3897-5861","position":2,"is_corresponding":false},{"id":614884,"name":"Laura J. Corbin","orcid":"0000-0002-4032-9500","position":3,"is_corresponding":false},{"id":240623,"name":"Tom G. Richardson","orcid":"0000-0002-7918-2040","position":4,"is_corresponding":false},{"id":1250960,"name":"Matthew A. Lee","orcid":"0000-0001-6262-3447","position":5,"is_corresponding":false},{"id":692381,"name":"James Yarmolinsky","orcid":"0000-0003-4371-0873","position":6,"is_corresponding":false},{"id":246453,"name":"Karl Smith-Byrne","orcid":"0000-0002-1932-7463","position":7,"is_corresponding":false},{"id":94945,"name":"David A. Hughes","orcid":"0000-0002-9644-8998","position":8,"is_corresponding":false},{"id":38786,"name":"Mattias Johansson","orcid":"0000-0002-3116-5081","position":9,"is_corresponding":false},{"id":218649,"name":"Ulrike Peters","orcid":"0000-0001-5666-9318","position":10,"is_corresponding":false},{"id":21999,"name":"Sonja I. Berndt","orcid":"0000-0001-5230-0652","position":11,"is_corresponding":false},{"id":22411,"name":"Hermann Brenner","orcid":"0000-0002-6129-1572","position":12,"is_corresponding":false},{"id":251131,"name":"Andrea N. Burnett‐Hartman","orcid":"0000-0003-4009-0680","position":13,"is_corresponding":false},{"id":252204,"name":"Iona Cheng","orcid":"0000-0003-4132-2893","position":14,"is_corresponding":false},{"id":251135,"name":"Sun‐Seog Kweon","orcid":"0000-0003-2378-8550","position":15,"is_corresponding":false},{"id":728,"name":"Loı̈c Le Marchand","orcid":"0000-0001-5013-980X","position":16,"is_corresponding":false},{"id":218625,"name":"Li Li","orcid":"0000-0003-1802-9517","position":17,"is_corresponding":false},{"id":218632,"name":"Polly A. Newcomb","orcid":"0000-0001-8786-0043","position":18,"is_corresponding":false},{"id":344383,"name":"Rachel Pearlman","orcid":"0000-0002-9293-5860","position":19,"is_corresponding":false},{"id":317316,"name":"Alex McConnachie","orcid":"0000-0002-7262-7000","position":20,"is_corresponding":false},{"id":537893,"name":"Paul Welsh","orcid":"0000-0002-7970-3643","position":21,"is_corresponding":false},{"id":569128,"name":"Roy Taylor","orcid":"0000-0001-6273-0170","position":22,"is_corresponding":false},{"id":1251375,"name":"Mike Lean","orcid":null,"position":23,"is_corresponding":false},{"id":42051,"name":"Naveed Sattar","orcid":"0000-0002-1604-2593","position":24,"is_corresponding":false},{"id":38978,"name":"Neil Murphy","orcid":"0000-0003-3347-8249","position":25,"is_corresponding":false},{"id":39449,"name":"Marc J. Gunter","orcid":"0000-0001-5472-6761","position":26,"is_corresponding":false},{"id":42602,"name":"Nicholas J. Timpson","orcid":"0000-0002-7141-9189","position":27,"is_corresponding":false},{"id":251143,"name":"Emma E. Vincent","orcid":"0000-0002-8917-7384","position":28,"is_corresponding":false},{"id":251129,"name":"Caroline J. Bull","orcid":"0000-0002-2176-5120","position":0,"is_corresponding":true}],"reference_count":61,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:00:52.633010Z","pmid":"38290287","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}